GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited [GLAXO.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

GLAXO.NS Stock Summary

Top 10 Correlated Stocks

GLAXO.NS

In the News

GLAXO.NS Financial details

Company Rating
Buy
Market Cap
318.72B
Income
5.29B
Revenue
33.11B
Book val./share
-
Cash/share
-
Dividend
32
Dividend %
1.45%
Employees
3.68K
Optionable
No
Shortable
Yes
Earnings
15 May 2024
P/E
57.9
Forward P/E
-
PEG
14.88
P/S
11.34
P/B
24.36
P/C
-
P/FCF
14805.81
Quick Ratio
1.32
Current Ratio
1.71
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
31.23
EPS next Y
-
EPS next Q
-
EPS this Y
60.36%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
6.52%
Revenue last 5Y
0.78%
Revenue Q/Q
-15.85%
EPS Q/Q
-78.97%
-
-
-
-
SMA20
-4.28%
SMA50
-16.36%
SMA100
19.32%
Inst Own
-
Inst Trans
-
ROA
20%
ROE
79%
ROC
0.49%
Gross Margin
61%
Oper. Margin
27%
Profit Margin
20%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1227.0-2524.0
52W High
-25.86%
52W Low
+52.5%
RSI
37
Rel Volume
0.27
Avg Volume
182.44K
Volume
49.2K
Perf Week
-3.04%
Perf Month
-13.89%
Perf Quarter
27.96%
Perf Half Y
21.99%
-
-
-
-
Beta
0.221
-
-
Volatility
12.15%, 68.01%
Prev Close
-0.9%
Price
1871.2
Change
-2.69%

GLAXO.NS Financial Performance

GLAXO.NS Dividend History

GLAXO.NS Frequently Asked Questions

What is GlaxoSmithKline Pharmaceuticals Limited stock symbol ?

GlaxoSmithKline Pharmaceuticals Limited is a IN stock and trading under the symbol GLAXO.NS

What is GlaxoSmithKline Pharmaceuticals Limited stock quote today ?

GlaxoSmithKline Pharmaceuticals Limited stock price is $1871.2 today.

Is GlaxoSmithKline Pharmaceuticals Limited stock public?

Yes, GlaxoSmithKline Pharmaceuticals Limited is a publicly traded company.

Something similar

Top by Market Cap
VOO
MIX.JO
GOOGL
1YD.DE
LLY.SW
Same Sector
084110.KQ
SZLS.TO
3737.HK
JUPW
MLND
Top Correlated Stocks
PFIZER.NS
1286.HK
8402.HK
Similar Market Cap
8111.T
9746.T
6592.T
TRIDENT.NS
001130.KS

Company Profile

Healthcare Drug Manufacturers - General
  • Volume Average 182.44K
  • Market Capitalization 318.72B
  • Employee 3.68K
  • CEO Mr. Bhushan Akshikar
  • Headquarters Mumbai,IN
  • IPO Date 2002-07-01
  • Website https://india-pharma.gsk.com

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.